APUS
Apimeds Pharmaceuticals US, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
Apimeds Pharmaceuticals US, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
3.01
−0.20 · −6.23%
post 2.88 −4.32%
−6.75%
shares held · 5 largest managers
No filed income statement.
No reported quarters.
No open-interest data.
Bar = avg |move| to ±8% · tick = ±7.0% avg day · ×base = |move| ÷ ±7.0% · min 6 releases
| Quarter | Reported | EPS | Consensus |
|---|---|---|---|
| Q2 FY26 | — | -11.77 | — |
| Q1 FY26 | — | -2.26 | — |
Source: filed financials
Expected move
No implied move.
No linked exposure.